Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population

Abstract

Despite modern advances in antiretroviral therapy and medical care, direct medical costs of HIV-1-infected patients increase after treatment switch and with lower CD4 counts, consistent with previous costing studies.